Form 4: Repligen Corp Director Exercises Stock Options, Acquires Shares
SEC Form 4 Filing
Repligen Corp director Anthony Hunt exercised stock options to acquire 11,808 shares of common stock at a price of $33.87 per share.
Summary
- Director Anthony Hunt of Repligen Corp exercised stock options on December 5, 2024.
- This transaction resulted in the acquisition of 11,808 shares of common stock at a price of $33.87 per share.
- Following the transaction, Mr. Hunt directly owns 151,648 shares of Repligen Corp.
- The stock options were part of a grant that vests over time, with some shares vesting on March 1st of 2025, 2026 and 2027.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction by a company director, which is generally viewed as neutral to slightly positive. The exercise of options suggests confidence in the company's future.
Positives
- The exercise of stock options by a director can be seen as a positive sign of confidence in the company's future performance.
- The director's increased stake in the company aligns his interests with those of other shareholders.
Industry Context
This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It provides transparency into the trading activities of company directors.
Comparison to Industry Standards
- Form 4 filings are a standard practice for all publicly traded companies in the US, ensuring transparency of insider transactions.
- The vesting schedule of the stock options is typical for executive compensation packages, aligning long-term incentives with company performance.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/05/2024 | Date of the stock option exercise and share acquisition. |
| 02/29/2028 | Expiration date of the stock options. |
| 03/01/2025 | Date when 2,952 shares of the stock options vest. |
| 03/01/2026 | Date when 2,952 shares of the stock options vest. |
| 03/01/2027 | Date when 2,952 shares of the stock options vest. |
Keywords
stock options, insider trading, beneficial ownership, Repligen Corp, RGEN, director, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.